环码生物完成数千万美元A轮融资

上海 – 2023年8月15日，上海环码生物医药有限公司（以下简称“环码生物”），一家基于独特环形RNA技术平台开发核酸药物的创新生物医药公司，宣布完成数千万美金A轮融资。本轮融资由强生创新-JJDC等领投，超弦基金等跟投。

CirCode

环码生物成立两年以来，完成了多项关键环形RNA技术的开发并搭建了完善的全球专利保护体系，这些技术为环形RNA药物开发铺平了道路。本轮融资将用于加速管线推进，推动环形RNA技术向药物的转化，造福广大病患。

CirCode Biomed Closes Multi-Million-Dollar Series A Financing

Shanghai, China – Aug.15^th, 2023, CirCode Biomed, an innovative biotechnology company focusing on the development of Circular RNA therapeutics, announced the completion of a multi-million-dollar Series A financing. The round was co-led by Johnson & Johnson Innovation – JJDC, Inc. and one other company, with participation from Superstring Capital and others.

CirCode

Founded 2 years ago, CirCode has achieved significant advancements in key technologies to pave the way for circular RNA drug development, and has multiple patent families covering this new technology and pending applications worldwide.

The funds raised in this round will be used to accelerate pipeline progress, facilitate the translation of circular RNA technology into therapies, and benefit a wide range of patients.